Aktuellt
SENASTE
Redeye comments on CLS’ strategy change with an increased focus on the neurosurgery segment. We highlight that the updated strategy could enable significant cost savings during the next couple of years and increase sales within the segment. However, this will also negatively affect sales within the urology segment. We will dig deeper into today’s news in our Q1 update next week.
LÄS MER
